Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Seeking new solutions for perinatal mental health

Regan Odysseus was scared. She'd tried Prozac before, but the medication made her mental health worse, leaving her unsure whether further treatment would help or hurt. But between her full-time job as an ICU nurse, her full-time job as a mom, and the hormone shifts from her second pregnancy, the pressure on her mental health was becoming unsustainable.

Seeking new solutions for perinatal mental health

Regan Odysseus, a full-time ICU nurse and mother of two, sought help for her worsening mental health during her second pregnancy. Despite previous negative experiences with medication, including Prozac, Odysseus was determined to address her depression and anxiety. She enrolled in a clinical trial led by perinatal psychiatrist Rana Jawish, MD, which combined cognitive behavioral therapy (CBT) with transcranial magnetic stimulation (TMS) as an alternative to medication.

Odysseus found the therapy's supportive environment and comprehensive care to be crucial in her improvement, experiencing increased well-being and a better ability to care for her family. However, the trial's small size and early phase make it difficult to definitively determine the effectiveness of TMS in pregnant populations. Jawish hopes to conduct larger studies to assess the treatment's efficacy and safety.

This trial highlights the importance of addressing maternal mental health, as poor mental health in pregnant people can have significant impacts on their families. Odysseus emphasizes that seeking help is a brave step, and encourages others going through similar struggles to reach out for support.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

Onshoring Is Here. The Hiring Wave Is Still a Decade Out

Building a highly technical, highly regulated pharmaceutical facility takes years, and we are in the part of the cycle where the work is physical, not scientific.

  • Pharmaceutical companies invested $370B in U.S. facilities since 2025.
  • Hiring surge for physical roles hasn't materialized yet.
  • Scientific workforce hiring expected within a decade.

More from Wednesday 5 August →